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In the eukaryotic cell cycle, several positive and negative factors regulate the cell cycle progression. Among the positive factors, the key molecules are a family of protein kinases each of which comprises a regulatory subunit, cyclin, and a catalytic subunit, termed a cyclindependent kinase (CDK) . A number of studies have suggested that cyclin D-CDK4/6 and cyclin E/A-CDK2 play important roles in promoting the transition from the G1 phase to the S phase by phosphorylating retinoblastoma tumor-suppressor gene (RB) product. One further level of control has recently become apparent, namely, the expression of cyclin-dependent kinase inhibitors (Sherr and Roberts, 1995) . Two families of CDK inhibitors were identified in mammalian cells, with different modes of action. One group, comprised of related proteins known as p21 Cip1/Waf1 , p27
Kip1 and p57 Kip2 inhibits cyclin E/A-CDK2 complexes (Harper and Elledge, 1996) . The second family of CDK inhibitors is also called INK4 family proteins. The four members of this family, designated p15 INK4b   , p16   INK4a   ,  p18 INK4c and p19 INK4d , bind directly to CDK4/6 and are specific inhibitors of the cyclin D-dependent kinases (Sherr and Roberts, 1999) .
The four proteins of the INK4 family possess a similar structure dominated by several ankyrin repeats and bind to CDK4/6 with similar affinity, but they were reported to have different biological roles. p16 INK4a functions as a tumor suppressor. Inactivation of the p16
INK4a gene through gene deletions, point mutations or transcriptional silencing by methylation of the promoter is one of the most frequent defects contributing to oncogenesis in human cancer (Ruas and Peters, 1998) . Consistently, mice deficient in p16
INK4a develop normally and are highly susceptible to malignant tumors (Krimpenfort et al., 2001; Sharpless et al., 2001) .
Disruption of p15
INK4b does not influence development of mice, but leads to frequent lymphoproliferative disorders (Latres et al., 2000) . Mice lacking p18
INK4c have enhanced epithelial cell growth, resulting in the frequent development of various types of neoplasia (Franklin et al., 1998; Latres et al., 2000) . p19
INK4d -deficient mice exhibit marked testicular atrophy associated with increased apoptosis of germ cells, suggesting an important role for p19
INK4d in testis development (Zindy et al., 2000) .
A possible molecular basis for these distinct biological functions was suggested to be caused by differences in the transcriptional regulation. In fact, the INK4 proteins are expressed in distinct, tissue-specific patterns (Zindy et al., 1997) . Furthermore, their transcription responds differentially to diverse stimuli. Induction of p15
INK4b in response to transforming growth factor b, or upregulation of p16 INK4a with increasing population doublings or oncogenic ras are typical examples of such differential transcriptional regulation (Hannon and Beach, 1994; Serrano et al., 1997) .
As described above, p18 INK4c -deficient mice exhibit frequent development of a wide spectrum of tumors, establishing p18
INK4c as a tumor-suppressor gene at least in mice (Franklin et al., 1998; Latres et al., 2000) . On the other hand, a number of studies suggested that genetic alterations of p18 INK4c gene are rare events in human tumors Otsuki et al., 1996; Rusin et al., 1996; Hatta et al., 1997) . However, it was recently reported that treatment of p18
INK4c null and heterozygous mice with a chemical carcinogen causes tumor at an accelerated rate (Bai et al., 2003 As shown by Western and Northern blot analysis, 12-O-tetradecanoylphorbol-13-acetate (TPA), widely used as a PKC activator (Nishizuka, 1984) , treatment of both human embryonic kidney (HEK) 293 T cells and human colon carcinoma HCT116 cells resulted in significant time-and dose-dependent downregulation of p18 To investigate how TPA affects cell growth of these cells at concentrations that downregulate p18
INK4c gene expression, we performed WST-1 assay. As shown in Figure 2a , TPA enhanced the growth of HCT116 cells in a dose-dependent manner (1 and 3 nM), but did not exhibit a growth-promoting effect on 293 T cells (2, 4, and 8 nM) (data not shown). HCT116 cells harbor wildtype RB (Yamamoto et al., 1999) , but 293 T cells carry RB inactivated by viral oncoproteins (Whyte et al., 1988) . Furthermore, the inhibition of cell growth by p18
INK4c depends on wild-type RB (Guan et al., 1994) . Therefore, the possibility is raised that the stimulatory effect of TPA on cell growth in HCT116 cells may be due to the downregulation of the p18
INK4c gene, and that the loss of enhancement of cell growth in 293 T cells may be attributed to the functionally inactivated RB.
Next, we examined whether the expressions of the other cell cycle-related molecules are altered with TPA in HCT116 cells by Western blot analysis. The abundance of p15
INK4b , p16
Cip1/Waf1 , p27
Kip1 and RB was unchanged or below the detection limit (Figure 2b ).
Since p18 INK4c is an inhibitor of the cyclin D-CDK4/6 complexes, we further investigated whether the phosphorylation status of RB is altered in TPA-treated HCT116 cells. RB is a key substrate for various cyclin-CDK complexes and specific sites are phosphorylated by distinct cyclin-CDK complexes (Kitagawa et al., 1996; Zarkowska and Mittnacht, 1997) . Therefore, we used antiphospho-RB (Ser 780 ) and antiphospho-RB (Thr   826   ) antibodies, which specifically recognize CDK4/6-phosphorylated residues Ser 780 and Thr 826 on RB, respectively (Kitagawa et al., 1996; Zarkowska and Mittnacht, 1997) . Western blot analysis demonstrated that 48 h after the treatment with TPA, RB protein recognized by antiphospho-RB (Ser 780 ) or antiphospho-RB (Thr   826   ) treated with TPA showed a stronger signal than that with vehicle only (Figure 2b) . By a densitometer analysis, the proportion of the phosphorylated RB (Ser 780 ) in the total RB protein after 48 h treatment with TPA to that after 48 h treatment with vehicle only was ) in the total RB protein after 48 h treatment with TPA to that after 48 h treatment with vehicle only was 100 to 72.
These findings raised the possibility that the reduction of p18
INK4c leads to the enhancement of cell growth in HCT116 cells. To test this hypothesis, we used the small interfering RNA (siRNA) technique to reduce the expression of p18
INK4c . HCT116 cells transfected with a double-stranded RNA (dsRNA) oligonucleotide for p18
INK4c showed a reduction of p18 INK4c protein compared with HCT116 cells transfected with a control dsRNA oligonucleotide (Figure 3a) . As expected, cells transfected with p18
INK4c oligonucleotide grew faster than those transfected with control oligonucleotide (Figure 3b ). These results indicate that p18
INK4c functions as a negative regulator of cell growth in HCT116 cells. Taken together with TPA induced-suppression of p18
INK4c
, it is suggested that p18
INK4c is a critical target of TPA to enhance cell growth.
To examine whether the downregulation of p18 INK4c gene expression by TPA is mediated through the PKC pathway, we employed Ro 31-8425 (Bit et al., 1993) , a potent and highly specific PKC inhibitor. As shown in Figure 4c and d, 293 T cells and HCT116 cells were simultaneously treated with Ro 31-8425 (20, 100 and 20 nM, respectively) together with or without TPA (8 and 3 nM, respectively). While the p18
INK4c gene expression was not affected by treatment with Ro 31-8425 alone, cotreatment of the PKC inhibitor with TPA prevented the TPA-induced downregulation of the p18
INK4c expression (Figure 4c, d ). As shown in Figure 4b , the suppressive effect on the p18 INK4c promoter activity by TPA was also repressed by the PKC inhibitor in 293 T cells. Taken together, these results indicate that the inhibitory effect of TPA on the p18
INK4c gene expression is mediated through the activation of PKC.
TPA induces the sequence-specific transcriptional factor AP-1, a heterodimer consisting of the c-Jun and c-Fos family members (Angel and Karin, 1991) . Overexpression of these genes is often associated with cell proliferation and malignant transformation (Angel and Karin, 1991) . Treatment with TPA induced AP-1 reporter activity in a dose-dependent fashion, with the maximal effect at 8 nM, in 293 T cells (data not shown). 0 -flanking region of human p18 INK4c gene was subcloned into the luciferase reporter plasmid pGVB2 (Nippon Gene). Reporter constructs were cotransfected with pRL-TK (Promega) to standardize by Renilla luciferase activity. 293 T cells (2 Â 10 5 cells) were transfected with a total of 0.816 mg DNA (0.8 mg reporter plasmid and 0.016 mg pRL -TK) using Lipofectin reagents (Invitrogen). Cells were incubated in a medium containing various concentrations of TPA (Wako), and were harvested 48 h after transfection. The luciferase activity of each cell lysate was measured using the Dual-Luciferase Reporter Plasmid System (Promega). The firefly luciferase activity of each sample was normalized by its Renilla luciferase activity and the fold activation was obtained by setting the value of control as 1.0. All transfection assays were carried out in triplicate. Data are shown as mean7s.d. Data were analysed using the Student's t-test. A P-value less than 0.05 was considered significant. A dominant-negative mutant of c-Jun cDNA was generated by PCR. The 0.6-kb PCR product was cloned into pcDNA3.1(À) (Invitrogen). TAM-67 expression vector and p18
INK4c reporter construct were cotransfected with pRL-CMV (Promega) to standardize by Renilla luciferase activity. 293 T cells (2 Â 10 5 cells) were transfected with a total of 0.903 mg DNA (0.7 mg effector plasmid, 0.175 mg reporter plasmid and 0.028 mg pRL-CMV) using Lipofectin reagents. Cells were incubated in a medium containing 8 nM of TPA, and were harvested 48 h after transfection. The luciferase activity of each cell lysate was measured using the Dual-Luciferase Reporter Plasmid System. The firefly luciferase activity of each sample was normalized by its Renilla luciferase activity and the fold activation was obtained by setting the value of control as 1.0. All transfection assays were carried out in triplicate. Data are shown as mean7s.d. Data were analysed using the Student's t-test. A P-value less than 0.05 was considered significant
